Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
2.985
+0.050 (1.70%)
Nov 10, 2026, 4:00 PM EST - Market closed
Nasus Pharma Employees
Nasus Pharma had 7 employees as of December 31, 2025. The number of employees increased by 5 or 250.00% compared to the previous year. That makes Nasus Pharma the 41,089th largest employer in the world and 6,269th in the United States.
Employees
7
Change (1Y)
5
Growth (1Y)
250.00%
Revenue / Employee
n/a
Profits / Employee
-$1,506,571
Market Cap
34.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 5 | 250.00% | 7 | 0 |
| Dec 31, 2024 | 2 | - | - | 1 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Grifols | 25,000 |
| Organon & Co. | 10,000 |
| Biogen | 7,500 |
| Amarin Corporation | 80 |
NSRX News
- 17 hours ago - Nasus Pharma Announces Abstracts Accepted for Presentation at ACAAI 2026 - GlobeNewsWire
- 11 days ago - Nasus Pharma initiated with a Buy at Maxim - TheFly
- 6 weeks ago - Nasus Pharma announces first patient enrolled, dosed in Phase 1 trial of NS003 - TheFly
- 6 weeks ago - Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron - GlobeNewsWire
- 1 month ago - Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis - GlobeNewsWire
- 2 months ago - Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Nasus Pharma files $50M ordinary shares offering - TheFly
- 2 months ago - Nasus Pharma Registration statement: Registration filing - Filings